Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
British Journal of Clinical Pharmacology
|
January 1, 1988
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients
R R Weber, C E McCoy, J A Ziemniak, et al.
Circulation
|
December 1, 1987
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam
M B Murphy, C E McCoy, R R Weber, et al.
Experimental Eye Research
|
November 1, 1988
Effects of selective dopamine-1 receptor activation on intraocular pressure in man
T A Karnezis, M B Murphy, R R Weber, et al.
Journal of Clinical Pharmacology
|
June 1, 1993
Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension
B L Pilmer, J A Green, E A Panacek, et al.
The American Journal of Cardiology
|
August 11, 1988
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride
R M Lang, K M Borow, A Neumann, et al.
Diabetes Care
|
February 24, 2001
Management of hyperglycemic crises in patients with diabetes
A E Kitabchi, G E Umpierrez, M B Murphy, et al.
Marine Pollution Bulletin
|
September 21, 2007
Distribution of perfluorinated compounds in surface seawaters between Asia and Antarctica
S Wei, L Q Chen, S Taniyasu, et al.
Circulation
|
March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension
W J Elliott, R R Weber, K S Nelson, et al.
Environment International
|
April 1, 2011
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China
H W Leung, T B Minh, M B Murphy, et al.
Circulation
|
February 15, 1995
Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients
B P Cholley, S G Shroff, J Sandelski, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
British Journal of Clinical Pharmacology
|
January 1, 1988
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients
R R Weber, C E McCoy, J A Ziemniak, et al.
Circulation
|
December 1, 1987
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam
M B Murphy, C E McCoy, R R Weber, et al.
Experimental Eye Research
|
November 1, 1988
Effects of selective dopamine-1 receptor activation on intraocular pressure in man
T A Karnezis, M B Murphy, R R Weber, et al.
Journal of Clinical Pharmacology
|
June 1, 1993
Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension
B L Pilmer, J A Green, E A Panacek, et al.
The American Journal of Cardiology
|
August 11, 1988
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride
R M Lang, K M Borow, A Neumann, et al.
Diabetes Care
|
February 24, 2001
Management of hyperglycemic crises in patients with diabetes
A E Kitabchi, G E Umpierrez, M B Murphy, et al.
Marine Pollution Bulletin
|
September 21, 2007
Distribution of perfluorinated compounds in surface seawaters between Asia and Antarctica
S Wei, L Q Chen, S Taniyasu, et al.
Circulation
|
March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension
W J Elliott, R R Weber, K S Nelson, et al.
Environment International
|
April 1, 2011
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China
H W Leung, T B Minh, M B Murphy, et al.
Circulation
|
February 15, 1995
Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients
B P Cholley, S G Shroff, J Sandelski, et al.
Page
of 13